jRCT2080222571未知3 期
A phase III long-term study to evaluate the safety and efficacy of TAC-202 in patients with perennial or seasonal allergic rhinitis.
试验速览
- 阶段
- 3 期
- 入组人数
- 120
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 干预模型
- Open Label
入排标准
- 年龄范围
- 18age old over 至 74age old under（—）
- 性别
- All
入选标准
- •Subjects who have been diagnosed with perennial allergic rhinitis and who have had related symptoms for 2 years or longer.
- •Subjects who have been diagnosed with seasonal allergic rhinitis and who have had related symptoms in Japanese ceder and Japanese cypress pollen season for 2 years or longer.
排除标准
- •Subjects who previously developed anaphylaxis to antihistamine drugs, or ingredients of the investigational drug.
- •Subjects with any of the following complications that may hinder efficacy evaluation.
- •Vasomotor rhinitis
- •Eosinophilic rhinitis
- •Drug-induced rhinitis
- •Viral conjunctivitis
- •Otitis media
- •Others (acute or chronic rhinitis, hypertrophic rhinitis, sinusitis, nasal polyps, repetitive nasal hemorrhage, treatment-requiring nasal septal deviation, etc.)
研究者
相似试验
已完成
3 期
A Phase II/III Study of TS-152 in Patients with Active Rheumatoid Arthritis (RA) Who Have Had an Inadequate Response to Methotrexate (MTX) TherapyjRCT2080223971Taisho Pharmaceutical co., LTD370
终止
2 期
A clinical study to learn whether a new drug, TPN-101, is safe when given to AGS patientsAicardi-Goutières Syndrome (AGS)Nervous System DiseasesISRCTN15569205Transposon Therapeutics, Inc16
已完成
3 期
Phase III clinical study of TY-0201 in patients with chronic atrial fibrillation -Confirmatory Study-jRCT2080222737TOA EIYO LTD.188
已完成
3 期
Phase III clinical study of TY-0201 in patients with chronic atrial fibrillation -long-term study-jRCT2080222649TOA EIYO LTD.100
未知
3 期
Z-103 Phase III Clinical Study in patients with Taste Disorder - A placebo-controlled superiority studytaste disorders induced by zinc-deficiencyJPRN-jRCT2080221862Zeria Pharmaceutical Co., Ltd.260